Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Persistent symptoms following SARS-CoV-2 infection are increasingly reported, although the drivers of post-acute sequelae (PASC) of COVID-19 are unclear. Here we assessed 214 individuals infected with SARS-CoV-2, with varying disease severity, for one year from COVID-19 symptom onset to determine the early correlates of PASC. A multivariate signature detected beyond two weeks of disease, encompassing unresolving inflammation, anemia, low serum iron, altered iron-homeostasis gene expression and emerging stress erythropoiesis; differentiated those who reported PASC months later, irrespective of COVID-19 severity. A whole-blood heme-metabolism signature, enriched in hospitalized patients at month 1-3 post onset, coincided with pronounced iron-deficient reticulocytosis. Lymphopenia and low numbers of dendritic cells persisted in those with PASC, and single-cell analysis reported iron maldistribution, suggesting monocyte iron loading and increased iron demand in proliferating lymphocytes. Thus, defects in iron homeostasis, dysregulated erythropoiesis and immune dysfunction due to COVID-19 possibly contribute to inefficient oxygen transport, inflammatory disequilibrium and persisting symptomatology, and may be therapeutically tractable.
Description
Keywords
Journal Title
Conference Name
Journal ISSN
1529-2916
Volume Title
Publisher
Publisher DOI
Sponsorship
Medical Research Council (MR/L019027/1)
Evelyn Trust (20/75)
MRC (via University of Birmingham) (1744863)
MRC (via University of Birmingham) (UK CIC UOB160996)
European Commission Horizon 2020 (H2020) Societal Challenges (733100)
Medical Research Council (MR/W018861/1)